Cellumen Competitors

At Charles River, we are guided by our strong purpose—to create healthier lives—which centers around the patients who rely on the therapeutics we help to develop, the animals in our care, to our planet, and to the passionate and skilled people who are at the heart of our organization and make it all possible. #DrugDiscovery #Biotech #Biotechnology #Pharmaceuticals #CRL

Medpace is a scientifically-driven, global, full-service clinical contract research organization (CRO) providing Phase I-IV clinical development services to the biotechnology, pharmaceutical and medical device industries. Medpace’s mission is to accelerate the global development of safe and effective medical therapeutics through its high-science and disciplined operating approach that leverages local regulatory and deep therapeutic expertise across all major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system and anti-viral and anti-infective. Headquartered in Cincinnati, Ohio, Medpace employs approximately 6,500 people across 46 countries.

In 2011, RFCL Limited of India was acquired by Avantor, a global supplier of ultra-high-purity materials for the life sciences and advanced technology markets, and renamed Avantor India in 2013. For more information about Avantor, visit www.avantorinc.com. Rankem™ brand chemicals from Avantor India provide a broad portfolio of materials to serve the growing needs of laboratory customers in India and related regional markets. For product information, visit www.rankem.in.